New molecular methods for classification, diagnosis and therapy prediction of hematological malignancies

Pathology and Oncology Research

Volumn 8, Issue 4, 2002, Pages 231-240

  Zvara, Ágnes ^a   Hackler Jr , László ^a   Nagy, B Zsolt ^a   Micsik, Tamás ^a   Puskás, László G ^a  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

DNA chip; Molecular methods; Oncohematology

Indexed keywords

MOLECULAR MARKER;

ACCURACY; ARTICLE; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CARCINOGENESIS; CELL FUNCTION; CHROMOSOME ABERRATION; DNA HYBRIDIZATION; DNA METHYLATION; DNA MICROARRAY; GENE CONTROL; GENE EXPRESSION; GENE FUNCTION; GENE LOCATION; GENE SEQUENCE; GENOME ANALYSIS; HEMATOLOGIC MALIGNANCY; HUMAN; MALIGNANT TRANSFORMATION; MOLECULAR GENETICS; OUTCOMES RESEARCH; PREDICTION; PROGNOSIS; SEQUENCE DATABASE; TECHNIQUE;

EID: 0037003670     PISSN: 12194956     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03036737     Document Type: Article

References (76)

1. Adorján P, Distler J. Lipscher E, et al: Tumour class prediction and discovery by microarray-based DNA methylation analysis. Nucleic Acids Res 30: e21, 2002.
2. Albala JS and Humphrey-Smith I: Array-based proteomics: high-throughput expression and purification of IMAGE consortium cDNA clones. Curr Opin Mol Ther 680-684, 1999.
3. Alizadeh AA, Ross DT, Perou CM, et al: Towards a novel classification of human malignancies based on gene expression patterns. J Pathol 195: 41-52, 2001.
4. Alwine JC, Kemp DJ, Stark GR: Method for detection of specific RNAs in agarose gels by transfer to diazobenzyloxymethyl-paper and hybridization with DNA probes. Proc Natl Acad Sci USA 74: 5350-5354, 1977.
5. Appelbaum FR: Molecular Diagnosis and Clinical Decisions in Adult Acute Leukemia, Seminars in Hematology 36: 401-410, 1999.
6. Arico M. Valsecchi MG, Camitta B et al: Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia. N Engl J Med 342: 998-1006, 2000.
7. Aubele M, Auer G. Braselmann H et al: Chromosomal imbalances are associated with metastasis-free survival in breast cancer patients. Anal Cell Pathol 24: 77-87, 2002.
8. Bittner M, Meltzer P, Chen Y et al: Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature 406: 536-540, 2000.
9. Blohm DH, Guiseppi-Elie A: New developments in microarray technology. Curr Opin Biotechnol 12: 41-47, 2001.
10. Bruckert P, Kappler R, Scherthan H et al: Double minutes and c-MYC amplification in acute myelogenous leukemia: Are they prognostic factors? Cancer Genet Cytogenet 120: 73-79, 2000.
11. Cahill DJ: Protein arrays: a high-throughput solution for proteomics research? Proteomics: A Trends Guide, 47-51, 2000.
12. Chan MF, Liang G and Jones PA: Relationship between transcription and DNA methylation. Curr Top Microbiol Immunol 249: 75-86, 2000.
13. Chen KT, Lin JD, Chao TC et al: Identifying differentially expressed genes associated with metastasis of follicular thyroid cancer by cDNA expression array. Thyroid 11: 41-46, 2001.
14. Clark J, Edwards S, John M et al: Identification of amplified and expressed genes in breast cancer by comparative hybridization onto microarrays of randomly selected cDNA clones. Genes Chromosomes Cancer 34: 104-114, 2002.
15. Costello JF, Fruhwald MC, Smiraglia DJ et al: Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nature Genet 24: 132-138, 2000.
16. DeRisi J, Penland L. Brown P et al: Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nature Genet 14: 457-460, 1996.
17. Dunican DS, McWilliam P, Tighe O et al: Gene expression differences between the microsatellite instability (MIN) and chromosomal instability (CIN) phenotypes in colorectal cancer revealed by high-density cDNA array hybridization. Oncogene 21: 3253-3257, 2002.
18. Eads CA, Danenberg KD, Kawakami K et al: MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res 28-c32, 2000.
19. Emili AQ and Cagney G: Large-scale functional analysis using peptide or protein arrays. Nat. Biotechnol 18: 393-397, 2000.
20. Ernst T, Hergenhahn M, Kenzelmann M et al: Decrease and gain of gene expression are equally discriminatory markers for prostate carcinoma: a gene expression analysis on total and microdissected prostate tissue. Am J Pathol 160: 2169-2180, 2002.
21. Esteller M, Corn PG, Baylin SB et al: A gene hypermethylation profile of human cancer. Cancer Res 61: 3225-3229, 2001.
22. Ferrando AA, Look AT: Clinical implications of recurring chromosomal and associated molecular abnormalities in acute lymphoblastic leukemia. Semin Hematol 37: 381-95, 2000.
23. Ferrando AA, Neuberg DS, Staunton J, et al: Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell, 1: 75-87, 2002.
24. Furák JI, Troján T Szõke L et al: Development of Brain Metastasis 5 Years Before the Appearance of the Primary Lung Cancer: Messenger Metachronous Metastasis. Annals Thoracic Surg (in press).
25. Gitan RS, Shi H, Chen CM et al: Methylation-specific oligonucleotide microarray: a new potential for high-throughput methylation analysis. Genome Res 12: 158-164, 2001.
26. Gilliland DG: Molecular Genetics of Human Leukemia. Leukemia 12: S7-S12, 1998.
27. Golub TR: The Genetics of AML: An Update in Proceedings of the American Society of Hematology, pp. 102-111, 1999.
28. Golub TR, Slonim DK, Tamayo P et al.: Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 286: 531-537, 1999.
29. Haab BB Dunham MJ, Brown PO: Protein microarrays for highly parallel detection and quantitation of specific proteins and antibodies in complex solutions. Genome Biol 2: Research 0004.1-0004.13, 2001.
30. Hanash SM, Madoz-Gurpide J, Misek DE: Identification of novel targets for cancer therapy using expression proteomics. Leukemia 16: 478-485, 2002.
31. Hedenfalk I, Duggan D, Chen Y et al: Gene-expression profiles in hereditary breast cancer. N Engl J Med 344: 539-548, 2001.
32. Hedrick SM, Cohen DI, Nielsen EA et al: Isolation of cDNA clones encoding T cell-specific membrane-associated proteins. Nature 308: 149-153, 1984.
33. Hodgson G, Hager JH, Volik S et al: Genome scanning with array CGH delineates regional alterations in mouse islet carcinomas. Nat Genet 29: 459-464, 2001.
34. Houldsworth J, Chaganti RS: Comparative genomic hybridization: an overview. Am J Pathol 145: 1253-1260, 1994.
35. Huang TH-M, Perry MR and Laux DE: Methylation profiling of CpG islands in human breast cancer cells. Hum Mol Genet 8:459-470, 1999.
36. Huang Y, Prasad M, Lemon WJ et al: Gene expression in papillary thyroid carcinoma reveals highly consistent profiles. Proc Natl Acad Sci USA 98: 15044-15049, 2001.
37. Jiang Y, Harlocker SL, Molesh DA et al: Discovery of differentially expressed genes in human breast cancer using subtracted cDNA libraries and cDNA microarrays. Oncogene 21: 2270-2282, 2002.
38. Jones PA: DNA methylation errors and cancer. Cancer Res 65: 2463-2467, 1996.
39. Kanerva J, Niini T, Vettenranta K et al: Loss at 12p detected by comparative genomic hybridization (CGH): association with TEL-AMLI fusion and favorable prognostic features in childhood acute lymphoblastic leukemia (ALL). A multi-institutional study. Med Pediatr Oncol 37: 419-425, 2001.
40. Kitajka K, Puská LG, Zvara Á. et al: The role of n-3 polyunsaturated fatty acids in brain: Modulation of rat brain gene expression by dietary n-3 fatty acids. Proc Natl Acad Sci USA 99, 2619-2624, 2002.
41. Kopper L, Tímár J: Gene expression profiles in the diagnosis and prognosis of cancer. Magy Onkol 46: 3-9, 2002.
42. Kozian DH, Kirschbaum BJ: Comparative gene-expression analysis. Trends Biotechnol 17: 73-78, 1999.
43. Kroll T, Odyvanova L, Clement JH et al: Molecular characterization of breast cancer cell lines by expression profiling. J Cancer Res Clin Oncol 128: 125-134, 2002.
44. Liang P, Pardee A et al: Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 257: 967-971, 1992.
45. Lin YM, Furukawa Y. Tsunoda T et al: Molecular diagnosis of colorectal tumors by expression profiles of 50 genes expressed differentially in adenomas and carcinomas. Oncogene 21: 4120-4128, 2002.
46. Lisitsyn N, Wiglet M et al: Cloning the differences between two complex genomes. Science 259: 946-951, 1993.
47. Luo JH, Yu YP, Cieply K et al: Gene expression analysis of prostate cancers. Mol Carcinog 33: 25-35, 2002.
48. Mitelman F, Mertens F, Johansson B: A breakpoint map of recurrent chromosomal rearrangements in human neoplasia. Nat Genet Spec No: 417-474, 1997.
49. Novak U, Oppliger Leibundgut E, Hager J et a: A high-resolution allelotype of B-cell chronic lymphocytic leukemia (B-CLL). Blood 100: 1787-1794, 2002.
50. Pinkel D, Segraves R, Sudar D et al: High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat Genet 20: 207-11, 1998.
51. Prashar Y, Weissman S et al: Analysis of differential gene expression by display of 3' end restriction fragments of cDNAs. Proc Nat Acad Sci USA 93: 659-663, 1996.
52. Pui CH, Campana D, Evans WE: Childhood acute lymphoblastic leukaemia current status and future perspectives. Lancet Oncol 10: 597-607, 2001.
53. Puskás LG, Zvara Á, Hackler JrL et al: RNA amplification results in reproducible microarray data with slight ratio biases. Biotechniques 32: 1330-1342, 2002.
54. Puskás LG, Zvara Á, Hackler JrL et al: Production of bulk amounts of universal RNA for DNA-microarrays. Biotechniques 33: 898-900, 902, 904, 2002.
55. Ramaswamy S. Tamayo P, Rifkin R et al: Multiclass cancer diagnosis using tumor gene expression signatures. Proc Natl Acad Sci USA 98: 15149-15154, 2001.
56. Rubnitz JE and Pui C-H: Leukemias, in Principles of Molecular Medicine, pp. 233-239. (J.L. Jameson ed.) Humana Press, NJ, 1998.
57. Schlossman SF, Chess L, Humphreys RE et al: Distribution of Ia-like molecules on the surface of normal and leukemic human cells. Proc Natl Acad Sci USA 73: 1288-1292, 1976.
58. Schwarze SR, DePrimo SE, Grabert LM et al: Novel pathways associated with bypassing cellular senescence in human prostate epithelial cells. J Biol Chem 277: 14877-14883, 2002.
59. Shipp MA, Ross KN, Tamayo P et al: Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning. Nat Med. 8: 68-74, 2002.
60. Shou J, Soriano R. Hayward SW et al: Expression profiling of a human cell line model of prostatic cancer reveals a direct involvement of interferon signaling in prostate tumor progression. Proc Natl Acad Sci USA 99: 2830-2835, 2002.
61. Sidransky D: Emerging molecular markers of cancer. Nature Rev Cancer 2: 210-219, 2002.
62. Strernmel C, Wein A, Hohenberger W et al: DNA microarrays: a new diagnostic tool and its implications in colorectal cancer. Int J Colorectal Dis 17: 131-136, 2002.
63. Suzuki H, Gabrielson E, Chen W et al: A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer. Nat Genet 31: 141-149, 2002.
64. Swaroop A, Xu JZ, Agarwal N et al: A simple and efficient cDNA library subtraction procedure: isolation of human retina-specific cDNA clones. Nucleic Acids Res 19: 1954, 1991.
65. Sweetser DA, Chert CS, Blomberg AA et al: Loss of heterozygosity in childhood de novo acute myelogenous leukemia. Blood 98: 1188-94, 2001.
66. Takano T, Hasegawa Y, Matsuzka F et al: Gene expression profiles in thyroid carcinomas Br J Cancer 83: 1495-502, 2000.
67. Toyota M, Ho C, Ahuja N et al: Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification. Cancer Res 59: 2307-2312, 1999.
68. Tsukasaki K, Krebs J, Nagai K et al: Comparative genomic hybridization analysis in adult T-cell leukemia/lymphoma: correlation with clinical course. Blood 97: 3875-3881, 2001.
69. Yeoh EJ, Ross ME, Shurtleff SAA et al: Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell 1: 133-143, 2002.
70. Velculescu VE, Zhang L, Vogelstein B et al: Serial analysis of gene expression. Science 270: 464-467, 1995.
71. Vogeli-Lange R, Burckert N, Boiler T et al: Rapid selection and classification of positive clones generated by mRNA differential display. Nucleic Acids Res 24: 1385-1386, 1996.
72. Weinberger SR, Morris TS, Pawlak M: Recent trends in protein biochip technology. Pharmacogenomics 1: 395-416, 2000.
73. Wieser R: Rearrangements of chromosome band 3q21 in myeloid leukemia. Leuk Lymphoma 43: 59-65, 2002.
74. Wilhelm M, Veltman JA, Olshen AB et al: Array-based comparative genomic hybridization for the differential diagnosis of renal cell cancer. Cancer Res 62: 957-960, 2002.
75. de Wit NJ, Burtscher HJ, Weidle UH et al: Differentially expressed genes identified in human melanoma cell lines with different metastatic behaviour using high density oligonucleotide arrays. Melanoma Res 12: 57-69, 2002.
76. Wreesmann VB, Ghossein RA, Patel SG et al: Genome-wide appraisal of thyroid cancer progression. Am J Pathol 161: 1549-1556, 2002.